Ref U. SET 017/2017 7 August 2017 Subject: Summary of Operating Performance and Financial Status for Quarter 2/2017 To: President The Stock Exchange of Thailand U City Public Company Limited and its

of Solvay Biochemicals (Taixing) Limited (“SBT”) amounting to 218 MB. Summary of Performance For Q2 2017, the Company and its subsidiaries recorded net profit of 384 MTHB, increased by 249 MTHB or 5.0

. * Note Please find further information in the consolidated financial statements. 2 Summary of Performance For Q3 2017, the Company and its subsidiaries recorded net profit of 355 MTHB, increased by 267

find further information in the consolidated financial statements. 2 Summary of Performance For Q2 2020, the Company and its subsidiary recorded net profit of 308 MTHB, decreased by 362 MTHB or 54.1

Microsoft Word - MD&A_2022 27 February 2023 Subject: Management Discussion and Analysis Ending 31 December 2022 To: The Managing Director The Stock Exchange of Thailand Unit: MB Summary of operating

have conducted the inspections on the quality control system in the last three years, specify such the department or agency, the period of inspection, scope of inspection, summary of the inspection

and (b) have a clear objective to share profits and costs and proportionate ownership, control or management power, have commons quality control system, business strategies, shared names or shared

the Audit Committee, and approved by the Company’s Board of Directors on February 20, 2020, the Company wishes to report further clarifications in summary as follows: Summary of the Company’s operating

. Financial highlights (based on Thai FRS) Q2 2019 Financial Position Summary as of 30 June 2019 compared to Q2 2018: H1 2019 Financial Position Summary as of 30 June 2019 compared to H1 2018 Note: Gross profit

Limited 4 MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 31 MARCH 2020 3. Financial highlights (based on Thai FRS) Q1 2020 Financial Position Summary as of 31 March 2020 compared to Q1 2019: Note